The applications of animal models in phage therapy: An update

The rapid increase in antibiotic resistance presents a dire situation necessitating the need for alternative therapeutic agents. Among the current alternative therapies, phage therapy (PT) is promising. This review extensively summarizes preclinical PT approaches in various in-vivo models. PT has be...

Full description

Bibliographic Details
Main Authors: Fazal Mehmood Khan, Prasanth Manohar, Vijay Singh Gondil, Nancy Mehra, Greater Kayode Oyejobi, Nelson Odiwuor, Tauseef Ahmad, Guangtao Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2023.2175519
_version_ 1797673098916397056
author Fazal Mehmood Khan
Prasanth Manohar
Vijay Singh Gondil
Nancy Mehra
Greater Kayode Oyejobi
Nelson Odiwuor
Tauseef Ahmad
Guangtao Huang
author_facet Fazal Mehmood Khan
Prasanth Manohar
Vijay Singh Gondil
Nancy Mehra
Greater Kayode Oyejobi
Nelson Odiwuor
Tauseef Ahmad
Guangtao Huang
author_sort Fazal Mehmood Khan
collection DOAJ
description The rapid increase in antibiotic resistance presents a dire situation necessitating the need for alternative therapeutic agents. Among the current alternative therapies, phage therapy (PT) is promising. This review extensively summarizes preclinical PT approaches in various in-vivo models. PT has been evaluated in several recent clinical trials. However, there are still several unanswered concerns due to a lack of appropriate regulation and pharmacokinetic data regarding the application of phages in human therapeutic procedures. In this review, we also presented the current state of PT and considered how animal models can be used to adapt these therapies for humans. The development of realistic solutions to circumvent these constraints is critical for advancing this technology.
first_indexed 2024-03-11T21:39:41Z
format Article
id doaj.art-53e1b30658e94010865fcbf7eae7e9ea
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:39:41Z
publishDate 2023-01-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-53e1b30658e94010865fcbf7eae7e9ea2023-09-26T13:25:48ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-01-0119110.1080/21645515.2023.21755192175519The applications of animal models in phage therapy: An updateFazal Mehmood Khan0Prasanth Manohar1Vijay Singh Gondil2Nancy Mehra3Greater Kayode Oyejobi4Nelson Odiwuor5Tauseef Ahmad6Guangtao Huang7Shenzhen UniversityVellore Institute of TechnologyChinese Academy of SciencesPostgraduate Institute of Medical Education and ResearchChinese Academy of SciencesChinese Academy of SciencesSoutheast UniversityThe First Affiliated Hospital of Shenzhen UniversityThe rapid increase in antibiotic resistance presents a dire situation necessitating the need for alternative therapeutic agents. Among the current alternative therapies, phage therapy (PT) is promising. This review extensively summarizes preclinical PT approaches in various in-vivo models. PT has been evaluated in several recent clinical trials. However, there are still several unanswered concerns due to a lack of appropriate regulation and pharmacokinetic data regarding the application of phages in human therapeutic procedures. In this review, we also presented the current state of PT and considered how animal models can be used to adapt these therapies for humans. The development of realistic solutions to circumvent these constraints is critical for advancing this technology.http://dx.doi.org/10.1080/21645515.2023.2175519phage therapyanimal infection modelantimicrobial resistanceeskape pathogensendolysin
spellingShingle Fazal Mehmood Khan
Prasanth Manohar
Vijay Singh Gondil
Nancy Mehra
Greater Kayode Oyejobi
Nelson Odiwuor
Tauseef Ahmad
Guangtao Huang
The applications of animal models in phage therapy: An update
Human Vaccines & Immunotherapeutics
phage therapy
animal infection model
antimicrobial resistance
eskape pathogens
endolysin
title The applications of animal models in phage therapy: An update
title_full The applications of animal models in phage therapy: An update
title_fullStr The applications of animal models in phage therapy: An update
title_full_unstemmed The applications of animal models in phage therapy: An update
title_short The applications of animal models in phage therapy: An update
title_sort applications of animal models in phage therapy an update
topic phage therapy
animal infection model
antimicrobial resistance
eskape pathogens
endolysin
url http://dx.doi.org/10.1080/21645515.2023.2175519
work_keys_str_mv AT fazalmehmoodkhan theapplicationsofanimalmodelsinphagetherapyanupdate
AT prasanthmanohar theapplicationsofanimalmodelsinphagetherapyanupdate
AT vijaysinghgondil theapplicationsofanimalmodelsinphagetherapyanupdate
AT nancymehra theapplicationsofanimalmodelsinphagetherapyanupdate
AT greaterkayodeoyejobi theapplicationsofanimalmodelsinphagetherapyanupdate
AT nelsonodiwuor theapplicationsofanimalmodelsinphagetherapyanupdate
AT tauseefahmad theapplicationsofanimalmodelsinphagetherapyanupdate
AT guangtaohuang theapplicationsofanimalmodelsinphagetherapyanupdate
AT fazalmehmoodkhan applicationsofanimalmodelsinphagetherapyanupdate
AT prasanthmanohar applicationsofanimalmodelsinphagetherapyanupdate
AT vijaysinghgondil applicationsofanimalmodelsinphagetherapyanupdate
AT nancymehra applicationsofanimalmodelsinphagetherapyanupdate
AT greaterkayodeoyejobi applicationsofanimalmodelsinphagetherapyanupdate
AT nelsonodiwuor applicationsofanimalmodelsinphagetherapyanupdate
AT tauseefahmad applicationsofanimalmodelsinphagetherapyanupdate
AT guangtaohuang applicationsofanimalmodelsinphagetherapyanupdate